SEC Filing Details
Document Details
Form
Filing Date
2026-04-02 12:53:11
Document Date
2026-04-02 12:53:11
Form Description
AMENDMENT NO. 5 TO SCHEDULE 13E-3
Filing Group
Current Reports
Company
Lakeshore Biopharma Co., Ltd.
Issuer
Lakeshore Biopharma Co., Ltd.